The company has issued more shares over this period, which dilutes each existing shareholder’s stake.
Diluted shares outstanding: 317K (2021) → 1.8M (2025)
Founded in Chicago, Illinois, in 2017, Cardio Diagnostics Holdings, Inc. specializes in the creation and market introduction of clinical tests. These diagnostic tools leverage epigenetics to assess cardiovascular disease risk. Among its offerings is Epi+Gen CHD, a test designed to predict the risk of symptomatic coronary heart disease over a three-year timeframe.
When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.
-28.3% YoY
YoY Growth Rate
Revenue declining
+47.4% YoY
YoY Growth Rate
EPS growth accelerating
$641,212/ year
↑ Rising (+181% vs prior year)
>1,000% of revenue
240.3x the sector average (18%)
Investing heavily in future products and technology
~12 months
$6M cash & investments
Quarterly Free Cash Flow
→ Burn rate stable
Adequate runway but may need to raise capital within 2 years
Cardio Diagnostics Holdings is putting 4325% of revenue into R&D and that number is rising. That's 240.3x the sector average.
The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.
Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.
Negative ROIC means the business is losing money on every dollar invested in it.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Free cash flow is negative. They are burning cash, not generating it.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
